G.L. Pharma GmbH Laboratorios Liconsa S.A.
PolandAll medications by this manufacturer
-
Tadomon
Form: tablets, prolonged release
Active substance Dosage tapentadol tartrate 41.9525 mg ATC: N02AX06
-
Tadomon
Form: tablets, prolonged release
Active substance Dosage tapentadol tartrate 83.905 mg ATC: N02AX06
-
Tadomon
Form: tablets, prolonged release
Active substance Dosage tapentadol tartrate 167.81 mg ATC: N02AX06
-
Tadomon
Form: tablets, prolonged release
Active substance Dosage tapentadol tartrate 251.715 mg ATC: N02AX06
-
Tadomon
Form: tablets, prolonged release
Active substance Dosage tapentadol tartrate 335.62 mg ATC: N02AX06
-
Tadomon
Form: tablets, prolonged release
Active substance Dosage tapentadol tartrate 419.525 mg ATC: N02AX06